This inventor holds 1 USPTO granted patent. Top assignee: Max-Delbrueck-Centrum Fuer Molekulare Medizin. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Joerg Huelsken: Innovator in Cardiovascular Treatment
Introduction
Joerg Huelsken is a prominent inventor based in Denges, Switzerland. He has made significant contributions to the field of cardiovascular medicine through his innovative research and patenting efforts. His work focuses on the treatment of cardiovascular diseases, particularly heart failure syndrome.
Latest Patents
Huelsken holds a patent for a remedy aimed at treating cardiovascular diseases or disorders. The patent discloses the use of inhibitors of β-catenin expression or activity, as well as modulators that downregulate β-catenin expression or activity. This innovative approach has shown promise in promoting cardiomyocyte differentiation of endogenous cardiac stem cells, offering new avenues for treating heart-related conditions.
Career Highlights
Joerg Huelsken is affiliated with the Max-Delbrueck-Centrum für Molekulare Medizin, where he conducts his research. His work has garnered attention for its potential impact on cardiovascular health and treatment methodologies. With a focus on innovative solutions, Huelsken continues to push the boundaries of medical science.
Collaborations
Some of his notable coworkers include Martin W. Bergmann and Walter Birchmeier. Their collaborative efforts contribute to the advancement of research in cardiovascular treatments and related fields.
Conclusion
Joerg Huelsken's contributions to cardiovascular medicine through his innovative patent and research efforts highlight his role as a key inventor in this critical area of healthcare. His work promises to enhance treatment options for patients suffering from cardiovascular diseases.